<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-06-04</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831569/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Spatial prioritization for widespread invasive species control: Trade-offs between current impact and future spread</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831569-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spatially explicit prioritization of invasive species control is a complex issue, requiring consideration of trade-offs between immediate and future benefits. This study aimed to prioritize management efforts to account for current and future threats from widespread invasions and examine the strength of the trade-off between these different management goals. As a case study, we identified spatially explicit management priorities for the widespread invasion of introduced willow into riparian &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831719/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831719-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Brain metastases (BM) constitute an increasing challenge in oncology due to their impact on neurological function, limited treatment options, and poor prognosis. BM occur through extravasation of circulating tumor cells across the blood-brain barrier. However, the extravasation processes are still poorly understood. We here propose a brain colonization process which mimics infarction-like microenvironmental reactions, that is dependent on Angiopoietin (Ang-2) and vascular endothelial &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831749/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831749-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epithelial-to-mesenchymal transition (EMT) is a classical cellular plasticity process induced by various cell-intrinsic and -extrinsic triggers. Although prominent factors, such as TGFβ, mediate EMT via well-characterized pathways, alternative avenues are less well understood. Transcriptomic subtyping of pancreatic ductal adenocarcinoma (PDAC) has demonstrated that basal-like PDACs enrich a mesenchymal-like expression program, emphasizing the relevance of EMT in the disease. In this issue &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831754/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831754-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A global consensus protocol has been developed for treatment planning for MR-guided pancreatic SBRT on a 1.5 T MR-Linac. Aside from harmonizing the large variation in the current clinical practice, this protocol can provide a starting point for centers that are planning to treat pancreatic tumors on MR-Linac &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831799/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Input precision, output excellence: the importance of data quality control and method selection in disease risk mapping -authors&#39; reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831799-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831935/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Expertise in surgical neuro-oncology. Results of a survey by the EANS neuro-oncology section</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831935-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Technical advances and the increasing role of interdisciplinary decision-making may warrant formal definitions of expertise in surgical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831996/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">The Radiation Therapist profession through the lens of new technology: A practice development paper based on the ESTRO Radiation Therapist Workshops</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831996-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Technological advances in radiation therapy impact on the role and scope of practice of the radiation therapist. The European Society of Radiotherapy and Oncology (ESTRO) recently held two workshops on this topic and this position paper reflects the outcome of this workshop, which included radiation therapists from all global regions. Workflows, quality assurance, research, IGRT and ART as well as clinical decision making are the areas of radiation therapist practice that will be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832018/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832018-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In this study, we optimized the dissociation of synovial tissue biopsies for single-cell omics studies and created a single-cell atlas of human synovium in inflammatory arthritis. The optimized protocol allowed consistent isolation of highly viable cells from tiny fresh synovial biopsies, minimizing the synovial biopsy drop-out rate. The synovium scRNA-seq atlas contained over 100,000 unsorted synovial cells from 25 synovial tissues affected by inflammatory arthritis, including 16 structural, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832418/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832418-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832863/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Transcranial transmission ultrasound for reliable non-invasive exclusion of intracranial hypertension in traumatic brain injury patients -A proof of concept study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832863-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    For many years, non-invasive methods to measure intracranial pressure (ICP) have been unsuccessful. However, such methods are crucial for the assessment of patients with non-penetrating traumatic brain injuries (TBI) who are unconscious. In this study, we explored the use of Transcranial Transmission Ultrasound (TTUS) to gather experimental data through brain pulsatility, assessing its effectiveness in detecting high ICP using machine learning analysis. We included patients with severe TBI &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832972/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832972-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Isatuximab-VRd was more effective than VRd as initial therapy in patients 18 to 80 years of age with newly diagnosed multiple myeloma who were ineligible to undergo transplantation. (Funded by Sanofi and a Cancer Center Support Grant; IMROZ ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832972/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832972-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Isatuximab-VRd was more effective than VRd as initial therapy in patients 18 to 80 years of age with newly diagnosed multiple myeloma who were ineligible to undergo transplantation. (Funded by Sanofi and a Cancer Center Support Grant; IMROZ ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38832994/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Side effects of oncologic therapies</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38832994-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38833159/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Scientific methods for in-vitro investigations in the field of joint kinematics : Cluster experimental joint kinematics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38833159-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    In vitro studies are an established method to determine joint kinematics for answering preclinical questions regarding the effects of new treatment options, surgical techniques or implant designs. The lack of standardized, interdisciplinary representation in the determination of joint kinematics poses a problem. In addition to representation forms such as the &ldquo;neutral-zero method&rdquo; or the description of movements within the three basic planes, there are other mathematical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38833160/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Tribology in arthroplasty : Friction and wear, a key to a long lifetime</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38833160-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This article is intended to highlight one of the key roles in endoprosthetic treatment with artificial implants and the extension of service life. Like every joint, artificial joints are subject to the physical laws of friction and wear-in short, tribology. Material pairings, surfaces and mechanisms of action in particular play a decisive role here. The special features and current findings relating to the three largest synovial joints (hip, knee and shoulder) will be discussed in detail &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Ohre7BQ0M">我从5:30下班，到现在快12:30了，一直坐在电脑前，看内网的各种专业资料和学习平台，不想去吃饭或睡觉，一直在读资料。这算是在满足我半辈子对HIV的好奇心。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ohre7bq0m/">
    
    
    
    
    
      
    
    我从5:30下班，到现在快12:30了，一直坐在电脑前，看内网的各种专业资料和学习平台，不想去吃饭或睡觉，一直在读资料。这算是在满足我半辈子对HIV的好奇心。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OhwHufkD4">今早NIH宣布将启动每半年注射一次Gilead开发的已上市药物Lenacapavir用于HIV预防PrEP临床试验，与口服PrEP进行对比。该临床试验将由HPTN开展（NCT06101329和NCT0...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ohwhufkd4/">
    
    
    
    
    
      
    
    今早NIH宣布将启动每半年注射一次Gilead开发的已上市药物Lenacapavir用于HIV预防PrEP临床试验，与口服PrEP进行对比。该临床试验将由HPTN开展（NCT06101329和NCT06101342）。STAT等媒体进行了报道。如果长效Lenacapavir不逊于日服PrEP，那么其使用方式将接近于疫苗，但保护力远高于疫苗。期待好消息。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhubAg2Ck">🔻笑死#清华博士送水泥戒指求婚被嘲笑# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohubag2ck/">
    
    
    
    
    
      
    
    🔻笑死<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#清华博士送水泥戒指求婚被嘲笑#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhujOpZZr">🔻“该视频同时有9个人正在观看”是怎么回事？🔻[哆啦A梦害怕] [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohujopzzr/">
    
    
    
    
    
      
    
    🔻“该视频同时有9个人正在观看”是怎么回事？<!-- raw HTML omitted -->🔻<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbgy1hqdq7b5yv6j20zu1nvk4x.jpg%22">https://tvax1.sinaimg.cn/large/639b1bfbgy1hqdq7b5yv6j20zu1nvk4x.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohuq2bYZo">🔻5 月份，财新制造业采购经理人指数从上月的 51.4 升至 51.7，创 2022 年 6 月以来新高，为约两年来最快，超过分析师预测的 51.5，从而提升了第二季度的前景...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohuq2byzo/">
    
    
    
    
    
      
    
    🔻5 月份，财新制造业采购经理人指数从上月的 51.4 升至 51.7，创 2022 年 6 月以来新高，为约两年来最快，超过分析师预测的 51.5，从而提升了第二季度的前景。<!-- raw HTML omitted -->🔻“但是”，路透社说，“但全球风险加大”。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhusOunQO">🔻5月美国及其狗腿在东亚侦察飞行的 ADB-S 雷达轨迹情况。🔻via vk/aboutplane [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohusounqo/">
    
    
    
    
    
      
    
    🔻5月美国及其狗腿在东亚侦察飞行的 ADB-S 雷达轨迹情况。<!-- raw HTML omitted -->🔻via vk/aboutplane <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhuWaqxmh">🔻以军国防部官网播出了以军参谋长在北方的讲话：🔹“我们正在接近必须做出决定的时刻，以色列国防军已经做好准备，随时可以出击——真主党最近几天增加了兵...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohuwaqxmh/">
    
    
    
    
    
      
    
    🔻以军国防部官网播出了以军参谋长在北方的讲话：<!-- raw HTML omitted -->🔹“我们正在接近必须做出决定的时刻，以色列国防军已经做好准备，随时可以出击——真主党最近几天增加了兵力。”<!-- raw HTML omitted -->🔻“加沙太难了，要不换张卷子做做”，然后它们真的就要选真主党？<!-- raw HTML omitted -->🔻纳斯鲁拉：呀哈比比，哈比比！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#巴勒斯坦#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_defaul">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_defaul</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhuX1AFcN">🔻黎巴嫩南部真主党这些年来的状态就像：#巴勒斯坦# 包容万物恒河水的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohux1afcn/">
    
    
    
    
    
      
    
    🔻黎巴嫩南部真主党这些年来的状态就像：<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#巴勒斯坦#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->&lt;div style=&ldquo;clear: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohux27P9S">🔻有些网友可能还没有理解为什么要选择“玄武岩国旗”进行原位利用的深意。🔻注意文中的“无温控保护、独立动态展示”。🔻意思就是，这面由超细玄武岩纤维...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohux27p9s/">
    
    
    
    
    
      
    
    🔻有些网友可能还没有理解为什么要选择“玄武岩国旗”进行原位利用的深意。<!-- raw HTML omitted -->🔻注意文中的“无温控保护、独立动态展示”。<!-- raw HTML omitted -->🔻意思就是，这面由超细玄武岩纤维编制而成的“石头国旗”，会在无温控保护的情况下，进行独立展示，接受高低温交变、高真空及强紫外辐射等极端环境的动态考验，通过持续观察国旗的状态，可以考验玄武岩纤维在月面环境下的长期耐久性。<!-- raw HTML omitted -->🔻玄武岩纤维的强度是同等直径钢纤维的两到三倍，耐腐蚀性超过合金，能承受200-300吨的重量，还能耐受超1000℃的高温和零下240℃的超低温，用玄武岩纤维制成防护服，能够耐温隔热抗辐射，它还能代替钢筋吊斜拉桥，200年不用维修，在油漆中添加玄武岩材料可提升重防腐作用，延长材料使用寿命。<!-- raw HTML omitted -->🔻而玄武岩与月壤的成分相似，这意味着如果真的能用，以后完全可以在月面取材建造……<!-- raw HTML omitted -->🔻没有一克载荷是多余的。<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26">https://m.weibo.cn/search?containerid=231522type%3D1%26</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohuz6eCZL">🔻莫迪又输了！🔻这次是输给了@JacksonHinkle [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohuz6eczl/">
    
    
    
    
    
      
    
    🔻莫迪又输了！<!-- raw HTML omitted -->🔻这次是输给了<!-- raw HTML omitted -->@JacksonHinkle<!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhuzNpgZI">🔻图2是图1的解释。🔻晚安。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohuznpgzi/">
    
    
    
    
    
      
    
    🔻图2是图1的解释。<!-- raw HTML omitted -->🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com">https://f.video.weibocdn.com</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohv6AjZwX">🔻在以色列国防军官方网站发布以军总参谋长“北方以军做好随时出击准备”视频后不久，黎巴嫩“真主党”武装就在其官方网站连续发布了两个视频：🔻一个是使用...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohv6ajzwx/">
    
    
    
    
    
      
    
    🔻在以色列国防军官方网站发布以军总参谋长“北方以军做好随时出击准备”视频后不久，黎巴嫩“真主党”武装就在其官方网站连续发布了两个视频：<!-- raw HTML omitted -->🔻一个是使用“伊朗高级导弹”袭击以军 Barkat Risha 哨所，导弹的导引头拍到了被命中的以军士兵特写，一个是使用无人机打掉戈兰高地扎乌拉地区的一具以军铁穹，也拍到了毁伤结果评估画面。<!-- raw HTML omitted -->🔻简直就快把“以军快北伐吧，简直等的要长蘑菇了”写在弹幕上了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#巴勒斯坦#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaimg.cn/orj480/639b1bfbly1hqdtn">https://tvax4.sinaimg.cn/orj480/639b1bfbly1hqdtn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Ohpwyu3XE">不错 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ohpwyu3xe/">
    
    
    
    
    
      
    
    不错 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhqmbbXKz">你的文字我喜欢🫰🏻//@僚姬://@普通人阿文:草//@Yashoku宵夜://@深夜茶座://@院厨_:（。 - 转发 @日语翻译社:&amp;ensp;周一！咖啡因注入！頑張る社会人に贈る！...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohqmbbxkz/">
    
    
    
    
    
      
    
    你的文字我喜欢🫰🏻//<!-- raw HTML omitted -->@僚姬<!-- raw HTML omitted -->://<!-- raw HTML omitted -->@普通人阿文<!-- raw HTML omitted -->:草//<!-- raw HTML omitted -->@Yashoku宵夜<!-- raw HTML omitted -->://<!-- raw HTML omitted -->@深夜茶座<!-- raw HTML omitted -->://<!-- raw HTML omitted -->@院厨_<!-- raw HTML omitted -->:（。<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@日语翻译社<!-- raw HTML omitted -->: 周一！<!-- raw HTML omitted -->咖啡因注入！<!-- raw HTML omitted -->頑張る社会人に贈る！ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/005yYAvcly1hqbyewqjtpj30b40b6771.jpg%22">https://tvax4.sinaimg.cn/large/005yYAvcly1hqbyewqjtpj30b40b6771.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhsrKBETc">晕了这张拍得好美🥹//@辉子_拓哦哦哦:妈呀蘭蘭 - 转发 @暁Mizuki:&amp;ensp;#のぎ動画# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohsrkbetc/">
    
    
    
    
    
      
    
    晕了这张拍得好美🥹//<!-- raw HTML omitted -->@辉子_拓哦哦哦<!-- raw HTML omitted -->:妈呀蘭蘭<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@暁Mizuki<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->#のぎ動画#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ohst63b77">不想洗碗不想写论文只想打剑网三完了我染上剑网三了😩</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohst63b77/">
    
    
    
    
    
      
    
    不想洗碗不想写论文只想打剑网三<!-- raw HTML omitted -->完了我染上剑网三了😩  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhtHbhc7W">听听首页广东人的惨叫👂🏻 - 转发 @迷惑行為大賞:&amp;ensp;？？？ [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohthbhc7w/">
    
    
    
    
    
      
    
    听听首页广东人的惨叫👂🏻<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@迷惑行為大賞<!-- raw HTML omitted -->: ？？？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhuLUumnN">像织儿本人 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里麦当劳 麦辣鸡块广告“你推哪种酱？”“我双推！” 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohuluumnn/">
    
    
    
    
    
      
    
    像织儿本人<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->麦当劳 麦辣鸡块广告<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->“你推哪种酱？”“我双推！”<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:">https://video.weibo.com/show?fid=1034:</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhuZlchSw">//@刑事課之虎牧高美和:转发微博 - 转发 @天涯明月刀OL官微:&amp;ensp;天涯明月刀OL [送花花]九载江湖路漫漫，归来仍是少年人！[打call]由刀刀联合同人作者们创作的#...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohuzlchsw/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@刑事課之虎牧高美和<!-- raw HTML omitted -->:转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@天涯明月刀OL官微<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhvaPtaHp">开心！</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohvaptahp/">
    
    
    
    
    
      
    
    开心！  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OhuP7nujh">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里麦当劳 麦辣鸡块广告“你推哪种酱？”“我双推！” 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ohup7nujh/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->麦当劳 麦辣鸡块广告<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->“你推哪种酱？”“我双推！”<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://video.weibo.com/show?fid=1034:5">https://video.weibo.com/show?fid=1034:5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OhpLT1I0S">棋手战鹰已经是1年前的事情了？？？ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ohplt1i0s/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->棋手战鹰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->已经是1年前的事情了？？？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OhudxggKY">久保史绪里麦当劳 麦辣鸡块广告“你推哪种酱？”“我双推！” 顶筆TEN使的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ohudxggky/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->麦当劳 麦辣鸡块广告<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->“你推哪种酱？”“我双推！”<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oht9fz2iY">柯柯也加油毕业[doge] - 转发 @棋士柯洁:&amp;ensp;想给2024即将参加高考的同学讲几句祝福的话🍀#高考加油##高考# 棋士柯洁的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oht9fz2iy/">
    
    
    
    
    
      
    
    柯柯也加油毕业<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@棋士柯洁<!-- raw HTML omitted -->: 想给2024即将参加高考的同学讲几句祝福的话🍀<!-- raw HTML omitted --><!-- raw HTML omitted -->#高考加油#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=2315">https://m.weibo.cn/search?containerid=2315</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OhthZEUkI">柯洁#柯柯b站动态搬运# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohthzeuki/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AFb%E7%AB%99%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Ohtic6Uor">柯洁#柯柯抖音动态搬运# 主播终于快要回归了！ [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohtic6uor/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%90%AC%E8%BF%90%23&amp;amp;extparam=%23%E6%9F%AF%E6%9F%AF%E6%8A%96%E9%9F%B3%E5%8A%A8%E6%80%81%E6%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/651838446/answer/3519760191">量子位回答了问题: mamba和transformer的差异是什么？未来mamba会取代transformer吗？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-651838446-answer-3519760191/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701543251">量子位发表了文章: 新架构Mamba更新二代！作者：别争了，已建立Transformer和SSM的统一理论框架</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701543251/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701546246">量子位发表了文章: 套壳丑闻让斯坦福AI Lab主任怒了！抄袭团队2人甩锅1人失踪、前科经历被扒，网友：重新认识中国开源模型</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701546246/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701582258">量子位发表了文章: 多模态模型学会打扑克：表现超越GPT-4v，全新强化学习框架是关键</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701582258/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701583523">量子位发表了文章: 3B模型新SOTA！开源AI让日常调用不同大模型更简单</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701583523/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701584055">量子位发表了文章: 直播预告｜对话汇智智能：AI Agent距离落地应用还有多远？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-04</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701584055/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38825871/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Prognosis and Treatment Strategies for Atrial Fibrillation in Heart Failure with Mildly Reduced Ejection Fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38825871-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: AF affects 43% of patients with HFmrEF and represents an independent predictor of adverse long-term &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38827999/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Intraocular lens calcification in a patient with Ehlers-Danlos syndrome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38827999-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND IMPORTANCE: Patients with systemic connective tissue disease, such as a subtype of Ehlers-Danlos, may present with secondary IOL calcification many years after primary lens insertion. This poses an additional consideration when implanting IOLs in these patients.Good visual acuity can be achieved with IOL &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828880/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Adolescent psychiatric inpatients&#39; perceptions of treatment and seclusion</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828880-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objectives: A great deal of attention is being directed at the use of seclusion in adolescent inpatient psychiatric units due to its forceful nature and negative impact on inpatients and staff. This mixed methods study aimed to explore and compare the level of satisfaction with the services received and perspectives on seclusion in secluded and non-secluded adolescent inpatients.Methods: This study included 188 participants, across three adolescent inpatient psychiatric units in Australia; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828929/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Small-Bowel Intussusception in an Adult</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828929-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828929/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Small-Bowel Intussusception in an Adult</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828929-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828933/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828933-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: As compared with DVd therapy, BVd therapy conferred a significant benefit with respect to progression-free survival among patients who had relapsed or refractory multiple myeloma after at least one line of therapy. Most patients had grade 3 or higher adverse events. (Funded by GSK; DREAMM-7 ClinicalTrials.gov number, NCT04246047; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828933/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828933-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: As compared with DVd therapy, BVd therapy conferred a significant benefit with respect to progression-free survival among patients who had relapsed or refractory multiple myeloma after at least one line of therapy. Most patients had grade 3 or higher adverse events. (Funded by GSK; DREAMM-7 ClinicalTrials.gov number, NCT04246047; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Malicious Midwives, Fruitful Vines, and Bearded Women - Sex, Gender, and Medical Expertise in the &lt;em&gt;Journal&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Malicious Midwives, Fruitful Vines, and Bearded Women - Sex, Gender, and Medical Expertise in the &lt;em&gt;Journal&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828945/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828945-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this phase 3 trial, crinecerfont was superior to placebo in reducing elevated androstenedione levels in pediatric participants with CAH and was also associated with a decrease in the glucocorticoid dose from supraphysiologic to physiologic levels while androstenedione control was maintained. (Funded by Neurocrine Biosciences; CAHtalyst Pediatric ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828945/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828945-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this phase 3 trial, crinecerfont was superior to placebo in reducing elevated androstenedione levels in pediatric participants with CAH and was also associated with a decrease in the glucocorticoid dose from supraphysiologic to physiologic levels while androstenedione control was maintained. (Funded by Neurocrine Biosciences; CAHtalyst Pediatric ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828946/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Osimertinib after Chemoradiotherapy in Stage III &lt;em&gt;EGFR&lt;/em&gt;-Mutated NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828946-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Treatment with osimertinib resulted in significantly longer progression-free survival than placebo in patients with unresectable stage III EGFR-mutated NSCLC. (Funded by AstraZeneca; LAURA ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828946/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Osimertinib after Chemoradiotherapy in Stage III &lt;em&gt;EGFR&lt;/em&gt;-Mutated NSCLC</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828946-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Treatment with osimertinib resulted in significantly longer progression-free survival than placebo in patients with unresectable stage III EGFR-mutated NSCLC. (Funded by AstraZeneca; LAURA ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828951/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828951-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among lenalidomide-exposed patients with relapsed or refractory myeloma, BPd conferred a significantly greater benefit than PVd with respect to progression-free survival, as well as deeper, more durable responses. Ocular events were common but were controllable by belantamab mafodotin dose modification. (Funded by GSK; DREAMM-8 ClinicalTrials.gov number, NCT04484623; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828951/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828951-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among lenalidomide-exposed patients with relapsed or refractory myeloma, BPd conferred a significantly greater benefit than PVd with respect to progression-free survival, as well as deeper, more durable responses. Ocular events were common but were controllable by belantamab mafodotin dose modification. (Funded by GSK; DREAMM-8 ClinicalTrials.gov number, NCT04484623; EudraCT number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828955/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828955-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients with CAH, the use of crinecerfont resulted in a greater decrease from baseline in the mean daily glucocorticoid dose, including a reduction to the physiologic range, than placebo following evaluation of adrenal androgen levels. (Funded by Neurocrine Biosciences; CAHtalyst ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828955/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828955-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients with CAH, the use of crinecerfont resulted in a greater decrease from baseline in the mean daily glucocorticoid dose, including a reduction to the physiologic range, than placebo following evaluation of adrenal androgen levels. (Funded by Neurocrine Biosciences; CAHtalyst ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828984/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240603181443&amp;v=2.18.0.post9&#43;e462414">Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828984-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240603181443-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients with resectable, macroscopic stage III melanoma, neoadjuvant ipilimumab plus nivolumab followed by surgery and response-driven adjuvant therapy resulted in longer event-free survival than surgery followed by adjuvant nivolumab. (Funded by Bristol Myers Squibb and others; NADINA ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38828984/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240604181823&amp;v=2.18.0.post9&#43;e462414">Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38828984-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240604181823-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Among patients with resectable, macroscopic stage III melanoma, neoadjuvant ipilimumab plus nivolumab followed by surgery and response-driven adjuvant therapy resulted in longer event-free survival than surgery followed by adjuvant nivolumab. (Funded by Bristol Myers Squibb and others; NADINA ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829073/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Azimuthal Angle Correlations of Muons Produced via Heavy-Flavor Decays in 5.02 TeV Pb&#43;Pb and pp Collisions with the ATLAS Detector</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829073-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Angular correlations between heavy quarks provide a unique probe of the quark-gluon plasma created in ultrarelativistic heavy-ion collisions. Results are presented of a measurement of the azimuthal angle correlations between muons originating from semileptonic decays of heavy quarks produced in 5.02 TeV Pb+Pb and pp collisions at the LHC. The muons are measured with transverse momenta and pseudorapidities satisfying p_{T}^{μ}&gt;4 GeV and |η^{μ}|&lt;2.4, respectively. The distributions of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829114/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829114-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The incidence rate of human papillomavirus-driven oropharyngeal cancer (HPV-OPC) is increasing in countries with high human development index. HPV cell-free DNA (cfDNA) isolated from 3 to 4 mL blood plasma has been successfully used for therapy surveillance. A highly discussed application of HPV-cfDNA is early detection of HPV-OPC. This requires sensitive and specific cfDNA detection as cfDNA levels can be very low. To study the predictive power of pre-diagnostic HPV-cfDNA, archived samples &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829320/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Better source memory for remembered to-be-forgotten items than for remembered to-be-remembered items</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829320-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    When participants study items one-by-one and are directed to either remember or forget the respective item directly after its presentation, retention of to-be-forgotten items is regularly worse than of to-be-remembered items. We tested whether this directed forgetting effect which is regularly observed for item memory generalizes to source memory. In three experiments, participants studied items in two different source colors (N = 101) or at two different source locations (N = 64; N = &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829401/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Implant anchorage: In vivo and in vitro analyses : Clusters for implant anchorage and safety</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829401-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Aseptic implant loosening is the primary cause of revisions in arthroplasty. Various in vitro and in vivo methods are available for assessing implant fixation and stability. The aim of the Musculoskeletal Biomechanics Research Network (MSB-NET) is to continuously improve or develop these methods. In vitro analyses are often conducted using static and dynamic ISO and ASTM standards, while RSA, DXA, and EBRA analyses are established in vivo methods for evaluating implant fixation. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829520/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Cardiac biomarkers prior to noncardiac surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829520-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Cardiac biomarkers, such as high-sensitivity cardiac troponin (hs-cTn) and brain natriuretic peptide (BNP) or N‑terminal prohormone of brain natriuretic peptide (NT-proBNP) are measured perioperatively to improve the prognosis and risk prediction. The European Society of Cardiology (ESC), European Society of Anesthesiology and Intensive Care (ESAIC) and the German Society of Anesthesiology and Intensive Care Medicine (DGAI) have recently published guidelines on the use of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829523/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Thanks to Prof. Dr. Roland Kaufmann : Board and editorial team thank the long-serving editor-in-chief of the journal Die Dermatologie</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829523-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38829625/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240603181530&amp;v=2.18.0.post9&#43;e462414">Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38829625-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240603181530-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: This study found that in patients with acute ischemic stroke, a dynamic change in hs-cTn values did not identify MI, underscoring that dynamic changes do not identify the underlying pathophysiological mechanism. In exploratory analyses, very high absolute hs-cTn values were associated with a diagnosis of type 1 MI. Further studies are needed how to best identify patients with stroke who should undergo coronary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38830892/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38830892-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There is a lack of knowledge regarding the relationship between proneness to dimensional psychopathological syndromes and the underlying pathogenesis across major psychiatric disorders, i.e., Major Depressive Disorder (MDD), Bipolar Disorder (BD), Schizoaffective Disorder (SZA), and Schizophrenia (SZ). Lifetime psychopathology was assessed using the OPerational CRITeria (OPCRIT) system in 1,038 patients meeting DSM-IV-TR criteria for MDD, BD, SZ, or SZA. The cohort was split into two samples &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38830959/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">CD8&lt;sup&gt;&#43;&lt;/sup&gt; CD28&lt;sup&gt;-&lt;/sup&gt; regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38830959-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38830985/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">RoPod, a customizable toolkit for non-invasive root imaging, reveals cell type-specific dynamics of plant autophagy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38830985-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Arabidopsis root is a classic model system in plant cell and molecular biology. The sensitivity of plant roots to local environmental perturbation challenges data reproducibility and incentivizes further optimization of imaging and phenotyping tools. Here we present RoPod, an easy-to-use toolkit for low-stress live time-lapse imaging of Arabidopsis roots. RoPod comprises a dedicated protocol for plant cultivation and a customizable 3D-printed vessel with integrated microscopy-grade glass &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38830991/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240604181742&amp;v=2.18.0.post9&#43;e462414">Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38830991-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240604181742-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    An unmet need exists for patients with relapsed/refractory (R/R) follicular lymphoma (FL) and high-risk disease features, such as progression of disease within 24 months (POD24) from first-line immunochemotherapy or disease refractory to both CD20-targeting agent and alkylator (double refractory), due to no established standard of care and poor outcomes. Chimeric antigen receptor (CAR) T cell therapy is an option in R/R FL after two or more lines of prior systemic therapy, but there is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831038/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">A bright green tag for RNA imaging</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831038-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831047/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Acute ischemic stroke and troponin elevation: update of the Mannheim clinical algorithm</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831047-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Elevated high-sensitivity cardiac troponin (hs-cTn) levels should be expected in about half of all patients with acute ischemic stroke (AIS). Since those patients are at risk of increased morbidity and mortality, often attributable to cardiac causes, an adequate work-up of the underlying etiology is required. This can only be achieved by a team of cardiologists and neurologists. Since underlying causes of hs-cTn elevation in AIS patients are diverse, often atypical or silent in their &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38831208/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240604181902&amp;v=2.18.0.post9&#43;e462414">Universal inverse modeling of point spread functions for SMLM localization and microscope characterization</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38831208-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240604181902-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The point spread function (PSF) of a microscope describes the image of a point emitter. Knowing the accurate PSF model is essential for various imaging tasks, including single-molecule localization, aberration correction and deconvolution. Here we present universal inverse modeling of point spread functions (uiPSF), a toolbox to infer accurate PSF models from microscopy data, using either image stacks of fluorescent beads or directly images of blinking fluorophores, the raw data &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OhfwX2wj3">晚饭在湾区地标餐厅Burlingame的Kincaid Fish庆祝一下。 美国·Burlingame [图片][图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ohfwx2wj3/">
    
    
    
    
    
      
    
    晚饭在湾区地标餐厅Burlingame的Kincaid Fish庆祝一下。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->美国·Burlingame<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OhodLdLMb">今天第一天上班充满了兴奋感。原来在Emeryville能看到Bay Bridge和SF（网页链接）；Gilead办公楼可以从西侧看SM Bridge。新办公室一切都是根据ergo（人体力学）...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ohodldlmb/">
    
    
    
    
    
      
    
    今天第一天上班充满了兴奋感。原来在Emeryville能看到Bay Bridge和SF（<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->网页链接<!-- raw HTML omitted --><!-- raw HTML omitted -->）；Gilead办公楼可以从西侧看SM Bridge。新办公室一切都是根据ergo（人体力学）设计的。今天食堂特色午饭是麻婆豆腐；而健身房里可以看着海湾跑步。Gilead离我家只有4分钟，中午可以回家。但最让我兴奋的是到处都是Biktarvy的AIDS或CROI poster，想想过去十年我不知道读这个药数据和写了多少评论。期待明天Crotty的报告，上次听他报告还是我读PhD的时候。 &lt;a href=&ldquo;<a href="http://weibo.com">http://weibo.com</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/OhgoVzL70">蓝胖子旁边，是一个铜锣烧专卖店，不知道这两家店是不是商量好的。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ohgovzl70/">
    
    
    
    
    
      
    
    蓝胖子旁边，是一个铜锣烧专卖店，不知道这两家店是不是商量好的。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Ohkrrgegi">第一次羡慕别人显示的IP地址…… - 转发 @嫦娥六号月球探测器:&amp;ensp;大家好，我是嫦娥六号，现在我正在月球挖土。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ohkrrgegi/">
    
    
    
    
    
      
    
    第一次羡慕别人显示的IP地址……<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@嫦娥六号月球探测器<!-- raw HTML omitted -->: 大家好，我是嫦娥六号，现在我正在月球挖土。 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/Ohfzuw7KY">《王安忆浙大文学课》出版。王老师签了很多书，送给当时整理录音的MFA同学们。这些同学已经毕业两年[心] [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ohfzuw7ky/">
    
    
    
    
    
      
    
    《王安忆浙大文学课》出版。王老师签了很多书，送给当时整理录音的MFA同学们。这些同学已经毕业两年<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/62b0d24fly1hqbx3jfp81j21400u0wk">https://tvax1.sinaimg.cn/large/62b0d24fly1hqbx3jfp81j21400u0wk</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OhgTR3YXX">倒是真的[awsl] - 转发 @头条新闻:&amp;ensp;#中国成年人焦虑症患病率已超过抑郁症#【比抑郁症更高发的心理疾病，正在侵袭中国4000多万成年人】#焦虑症不治疗后果有...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ohgtr3yxx/">
    
    
    
    
    
      
    
    倒是真的<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@头条新闻<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E5%9B%BD%E6%88%90%E5%B9%B4%E4%BA%BA%E7%84%A6%E8%99%91%E7%97%87%E6%82%A3%E7%97%85%E7%8E%87%E5%B7%B2%E8%B6%85%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%AD%E5%9B%BD%E6%88%90%E5%B9%B4%E4%BA%BA%E7%84%A6%E8%99%91%E7%97%87%E6%82%A3%E7%97%85%E7%8E%87%E5%B7%B2%E8%B6%85%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1655755343/OhikFmqgn">去买荔枝汁，店员说很甜哦，我说好，她说真的很甜哦，我说好的不买了。她说好[老师好]总而言之略懂，这种平平淡淡、ai无法做到的毁灭感。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1655755343-ohikfmqgn/">
    
    
    
    
    
      
    
    去买荔枝汁，店员说很甜哦，我说好，她说真的很甜哦，我说好的不买了。她说好<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->总而言之略懂，这种平平淡淡、ai无法做到的毁灭感。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhkNQbEfp">🔻有个问题嗷：这几家这么闪崩了（或者说故障了），为什么指数没动啊[哆啦A梦吃惊]🔻你们华尔街玩模拟盘的吗？#伯克希尔哈撒韦# [图片][图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohknqbefp/">
    
    
    
    
    
      
    
    🔻有个问题嗷：这几家这么闪崩了（或者说故障了），为什么指数没动啊<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->🔻你们华尔街玩模拟盘的吗？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#伯克希尔哈撒韦#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbgy1hqck6af31jj21gi0xc1kx.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbgy1hqck6af31jj21gi0xc1kx.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhkRb4As8">这家有道意大利人震怒菜：宫保鸡丁～披萨🍕 - 转发 @九吃:&amp;ensp;澳门米夫老师来蓉，相邀见面一叙，畅娃全程安排，他们吃了午饭，约到人民公园鹤鸣茶社体验四川...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohkrb4as8/">
    
    
    
    
    
      
    
    这家有道意大利人震怒菜：宫保鸡丁～披萨🍕<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@九吃<!-- raw HTML omitted -->: 澳门米夫老师来蓉，相邀见面一叙，畅娃全程安排，他们吃了午饭，约到人民公园鹤鸣茶社体验四川人的茶文化。这地方已经成了外地人打卡地，人山不海，本地人都不太敢去了，根本抢不到位子。今天这天气，喝茶摆龙门阵还是相当惬意，晚餐就近去蓉槿荟，新店环境好，不久前大家都去吃过，请客也不踩雷。米夫怕辣，我们就让他见识川菜味型的丰富度，其实就算大白鱼这样的酸辣和口水鸡这样的麻辣，他完全可以接受，好的川菜，只会是以辣促香，而不是为了辣而辣。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/8105f481gy1hqck8oc54qj21">https://tvax4.sinaimg.cn/large/8105f481gy1hqck8oc54qj21</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhkSVweoG">🔻看看微博小尾巴</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohksvweog/">
    
    
    
    
    
      
    
    🔻看看微博小尾巴  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhkXchYu5">🔻“当报告市场的一举一动的是人工智能时，还有什么可能出错呢？”🔻彭博自动化演给你看。#数只美股疑似出现行情异常# [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohkxchyu5/">
    
    
    
    
    
      
    
    🔻“当报告市场的一举一动的是人工智能时，还有什么可能出错呢？”<!-- raw HTML omitted -->🔻彭博自动化演给你看。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#数只美股疑似出现行情异常#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhkZqemJW">🔻来，重温一下2008年雷曼兄弟破产。🔻说不定这素材没多久就能用得上了。#数只美股疑似出现行情异常#</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohkzqemjw/">
    
    
    
    
    
      
    
    🔻来，重温一下2008年雷曼兄弟破产。<!-- raw HTML omitted -->🔻说不定这素材没多久就能用得上了。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#数只美股疑似出现行情异常#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaimg.cn/orj480/639b1bfbly1hqckzpmun0j20t60jqaax">https://tvax4.sinaimg.cn/orj480/639b1bfbly1hqckzpmun0j20t60jqaax</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohl3T6YXM">🔻泽连斯基用战争威胁菲律宾人：“如果乌克兰失败，如果俄罗斯完全占领我们，我们将在其他大陆看到这场战争。它可能就在你们的方向，在你们的地区。这是一场大...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohl3t6yxm/">
    
    
    
    
    
      
    
    🔻泽连斯基用战争威胁菲律宾人：“如果乌克兰失败，如果俄罗斯完全占领我们，我们将在其他大陆看到这场战争。它可能就在你们的方向，在你们的地区。这是一场大悲剧。受害者众多。我们绝不能让俄罗斯获胜。”<!-- raw HTML omitted -->🔻它可能不了解菲律宾人。<!-- raw HTML omitted -->🔻菲律宾人：“现在，俄国人在我们的海滩上到处都是啊？”<!-- raw HTML omitted -->🔻via RTVM <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->包容万物恒河水的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohl423lp9">🔻首页全是对着月球宣示“自古以来”的。</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohl423lp9/">
    
    
    
    
    
      
    
    🔻首页全是对着月球宣示“自古以来”的。  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohl5NzcX9">🔻你这又有点搞笑了，拉这么一下什么意思？#数只美股疑似出现行情异常# [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohl5nzcx9/">
    
    
    
    
    
      
    
    🔻你这又有点搞笑了，拉这么一下什么意思？<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#数只美股疑似出现行情异常#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ohldw2SAW">🔻迈向深蓝。🔻晚安。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohldw2saw/">
    
    
    
    
    
      
    
    🔻迈向深蓝。<!-- raw HTML omitted -->🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OhljhesHF">？//@北斗_玉衡:不要睡啊，明天上午嫦娥六号要从月球起飞了～ - 转发 @包容万物恒河水:&amp;ensp;🔻迈向深蓝。🔻晚安。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ohljheshf/">
    
    
    
    
    
      
    
    ？//<!-- raw HTML omitted -->@北斗_玉衡<!-- raw HTML omitted -->:不要睡啊，明天上午嫦娥六号要从月球起飞了～<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@包容万物恒河水<!-- raw HTML omitted -->: 🔻迈向深蓝。<!-- raw HTML omitted -->🔻晚安。 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Ohjzk5kiS">拼命累积起来的东西绝对不会背叛自己。对么？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ohjzk5kis/">
    
    
    
    
    
      
    
    拼命累积起来的东西绝对不会背叛自己。<!-- raw HTML omitted --><!-- raw HTML omitted -->对么？  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Ohh32y5Xy">蛾眉豆又叫鹅米豆，我老家叫“刀刀”。今年自家播种的刀刀，开花，结了六七个豆荚。我说明天就出发了，今天摘下来吃了吧。喵奶奶说太嫩了嘛，等我们旅游回来再摘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ohh32y5xy/">
    
    
    
    
    
      
    
    蛾眉豆又叫鹅米豆，我老家叫“刀刀”。今年自家播种的刀刀，开花，结了六七个豆荚。我说明天就出发了，今天摘下来吃了吧。喵奶奶说太嫩了嘛，等我们旅游回来再摘？我说呵呵，等我们旅游回来，豆荚可能长得比你都还老了。喵奶奶淡然一笑，如果两三年前我这样说，她会横眉怒目跟我毛起：你有好年轻嘛！现在乘公交刷老年卡，心态也慢慢平和了。她说才六七个豆荚，不够一盘菜，我说我不晓得去湖夹滩买？湖夹滩蔬菜一条街的刀刀叫“鹅米豆”，价格不菲，5元/斤。买了半斤多，与自己种的刀刀一起，组合成一盘菜。<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OhjtGmjAZ">第一次乘坐Qatar Airways的航班，起飞前24-36小时，可以网上值机，但我从午后2：00等到现在，还没开始。据说Qatar Airways 是国际一流航空公司，但网上值机时间...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ohjtgmjaz/">
    
    
    
    
    
      
    
    第一次乘坐Qatar Airways的航班，起飞前24-36小时，可以网上值机，但我从午后2：00等到现在，还没开始。据说Qatar Airways 是国际一流航空公司，但网上值机时间咋个这么折磨人呢？ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OhfS9AtRe">完美[怒] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ohfs9atre/">
    
    
    
    
    
      
    
    完美<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OhgLv9CAl">像俩不太会下棋的人在下 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ohglv9cal/">
    
    
    
    
    
      
    
    像俩不太会下棋的人在下 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OhhTyAObN">柯洁这棋也能输是吧</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-ohhtyaobn/">
    
    
    
    
    
      
    
    柯洁这棋也能输是吧  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhiK1qMWe">IMQR//@废话巨多R:IMSB//@疯狂怪叫鹦:PFMN//@最弱番长斩真豪:我是INCEL//@西木野熊-Mk2:我是ICBM//@柚子_YUZU:我是YUZU//@优家小花茶:我是BABY[爱你]//@Mona健康...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohik1qmwe/">
    
    
    
    
    
      
    
    IMQR//<!-- raw HTML omitted -->@废话巨多R<!-- raw HTML omitted -->:IMSB//<!-- raw HTML omitted -->@疯狂怪叫鹦<!-- raw HTML omitted -->:PFMN//<!-- raw HTML omitted -->@最弱番长斩真豪<!-- raw HTML omitted -->:我是INCEL//<!-- raw HTML omitted -->@西木野熊-Mk2<!-- raw HTML omitted -->:我是ICBM//<!-- raw HTML omitted -->@柚子_YUZU<!-- raw HTML omitted -->:我是YUZU//<!-- raw HTML omitted -->@优家小花茶<!-- raw HTML omitted -->:我是BABY&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhizGkq1A">转发微博 - 转发 @Amerenka:&amp;ensp;岩本莲加#岩本莲加# 我是乃木坂46的岩本莲加 第一次出演超乃木坂star诞生 第一次单独唱歌十分紧张 我要演唱的是あたらよ的交差...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohizgkq1a/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@Amerenka<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->岩本莲加<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhjeQD1TQ">们紫紫的歌紫味儿真重（</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohjeqd1tq/">
    
    
    
    
    
      
    
    们紫紫的歌紫味儿真重（  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhjiunoCC">勾八散热器不如小风扇好使 [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohjiunocc/">
    
    
    
    
    
      
    
    勾八散热器不如小风扇好使 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhjOQ4T5I">啊？//@山下月太郎:？//@回转与天使:？？？？？？谁和谁？？ - 转发 @女团拉娘大饭店:&amp;ensp;韩娱拉娘【40095】姜海粼×早川圣来《如果我抓不住》 [图片][图片][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohjoq4t5i/">
    
    
    
    
    
      
    
    啊？//<!-- raw HTML omitted -->@山下月太郎<!-- raw HTML omitted -->:？//<!-- raw HTML omitted -->@回转与天使<!-- raw HTML omitted -->:？？？？？？谁和谁？？<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@女团拉娘大饭店<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhkmwpUNJ">麦！ [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohkmwpunj/">
    
    
    
    
    
      
    
    麦！ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhlIkkMCy">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.06.03 13:50「哦吼吼」早上好〜希望今天也是美好的一天…！如何运用时间。我认为有时候适...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohlikkmcy/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/se">https://m.weibo.cn/se</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OhlInjbVY">转发微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#久保史绪里手机博# 2024.06.03 21:06「呜呼呼」久保史绪里虽然有点暗，但偶尔发发也可以吧 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohlinjbvy/">
    
    
    
    
    
      
    
    转发微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ohm44q8WA">晕了 - 转发 @千葉鱿鱼:&amp;ensp;🎵あたらよ「交差点」🎤 岩本蓮加 千葉鱿鱼的微博视频</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohm44q8wa/">
    
    
    
    
    
      
    
    晕了<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@千葉鱿鱼<!-- raw HTML omitted -->: 🎵あたらよ「交差点」<!-- raw HTML omitted -->🎤 岩本蓮加 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->千葉鱿鱼的微博视频<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax1.sinaimg.cn/orj480/e1c2f1e1gy1hqcp5pgcogj21hc0u0kjl.jp">https://tvax1.sinaimg.cn/orj480/e1c2f1e1gy1hqcp5pgcogj21hc0u0kjl.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ohm5L1tbl">9命——莲糖的鼻音，谁懂🚬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ohm5l1tbl/">
    
    
    
    
    
      
    
    9命——莲糖的鼻音，谁懂🚬  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OhirNrYom">轉發微博 - 转发 @顶筆TEN使:&amp;ensp;久保史绪里#shiorigram# .坦率一点不也挺好的呀5月。坦率一点不也挺棒的吗6月。 [图片][图片][图片][图片][图片][图片][图片]...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-ohirnryom/">
    
    
    
    
    
      
    
    轉發微博<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@顶筆TEN使<!-- raw HTML omitted -->: <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;amp;extparam=%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OhkRmjjxQ">野狐，梭哈小申破产幽玄，全服第一[二哈] [图片][图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ohkrmjjxq/">
    
    
    
    
    
      
    
    野狐，梭哈小申破产<!-- raw HTML omitted -->幽玄，全服第一<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Ohl494oI4">发布了头条文章：《平塚道场——赵治勋《我的履历书》（8）》 #围棋# 围棋 平塚道场——赵治勋《我的履历书》（8） [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ohl494oi4/">
    
    
    
    
    
      
    
    发布了头条文章：《平塚道场——赵治勋《我的履历书》（8）》 <!-- raw HTML omitted --><!-- raw HTML omitted -->#围棋#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->围棋<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OhlvPrhmT">久保史绪里#久保史绪里手机博# 2024.06.03 21:06「呜呼呼」久保史绪里虽然有点暗，但偶尔发发也可以吧 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ohlvprhmt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ohlvt8PN1">久保史绪里#久保史绪里手机博# 2024.06.03 13:50「哦吼吼」早上好〜希望今天也是美好的一天…！如何运用时间。我认为有时候适合密集地工作也有时候适合休息。知...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ohlvt8pn1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->久保史绪里<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OhhaWob6n">柯洁#2024乐居乐杯中国围棋甲级联赛#VX号正在直播[666] [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohhawob6n/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%258">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%232024%E4%B9%90%E5%B1%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Ohi6FoacV">柯洁#2024乐居乐杯中国围棋甲级联赛##赛果发布# 2024乐居乐杯中国围棋甲级联赛常规赛第三轮，柯洁九段执黑228手中盘负薛冠华六段。 作死第一名了属于。 [图片]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohi6foacv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%232024%E4%B9%90%E5%B1%85%E4%B9%90%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8%81%94%E8%B5%9B%23&amp;amp;extparam=%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OhiGAFpLU">柯洁时越胜古灵益，柯洁负薛冠华，陶欣然胜刘兆哲，朴廷桓胜陈耀烨。深圳龙华队3:1开封奕教队 - 转发 @柯洁九段新闻搬运号:&amp;ensp;柯洁#2024乐居乐杯中国围棋甲级...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohigafplu/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted -->时越胜古灵益，柯洁负薛冠华，陶欣然胜刘兆哲，朴廷桓胜陈耀烨。深圳龙华队3:1开封奕教队<!-- raw HTML omitted --><!-- raw HTML omitted --> - 转发 <!-- raw HTML omitted -->@柯洁九段新闻搬运号<!-- raw HTML omitted -->: &lt;a href=&ldquo;<a href="https://m.weibo.cn/p/index?extparam=%E6%9F%AF%E6%B4%81">https://m.weibo.cn/p/index?extparam=%E6%9F%AF%E6%B4%81</a>&amp; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OhkfBr4mn">柯洁#六月赛程#暑气渐深，围甲也渐入高潮，本月将展开四轮激烈的角逐。月中则是传统赛事，柯洁九段屡战屡败屡败屡战的，烂柯国内赛。围甲新赛制下的龙华将取得怎...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-ohkfbr4mn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->柯洁<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/346720235/answer/3043498669">王诗翔赞同了回答: 国内的学术氛围到底怎么样？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-346720235-answer-3043498669/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657677178/answer/3518397392">张敬信回答了问题: 为什么华为手机如此钟爱骁龙680？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657677178-answer-3518397392/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/657971226/answer/3518797946">量子位回答了问题: 如何看待斯坦福 AI 团队被曝抄袭中国面壁开源模型？开源如何维护权益？</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-657971226-answer-3518797946/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701317251">量子位发表了文章: OpenAI把GPT-4原始版给了他们：研究不微调只靠提示词能走多远</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701317251/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701337413">量子位发表了文章: 中科院自动化所研发脉冲动态计算的毫瓦级超低功耗异步感算一体类脑芯片</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701337413/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701345702">量子位发表了文章: 斯坦福团队被曝抄袭清华系大模型，已删库跑路</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701345702/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701349528">量子位发表了文章: 英伟达新研究：上下文长度虚标严重，32K性能合格的都不多</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701349528/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701356541">量子位发表了文章: ICML2024高分！魔改注意力，让小模型能打两倍大的模型</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701356541/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://zhuanlan.zhihu.com/p/701445346">量子位发表了文章: 昆仑万维开源2千亿稀疏大模型天工MoE，全球首创能用4090推理</a></h1>
  <div class="date-author">
    
    <span class="date">2024-06-03</span>
  </div>
  <div class="summary">
    <a href="/post/zhuanlan-zhihu-com-p-701445346/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

